Ingrid Yin covers China health care as Managing Director and Senior Analyst for Oppenheimer & Co. Inc. Dr. Yin joined Oppenheimer from Brean Murray, Carret & Co., LLC, where she was the Senior Analyst for China health care since 2009. Before her work at Brean Murray, she was an Asian Equity Analyst at Wellington Management in emerging markets. Dr. Yin also has held positions at Jefferies Asset Management and Sirios Capital Management. Before moving to Wall Street, Dr. Yin was a Senior Research Scientist at Memorial Sloan-Kettering Cancer Center in New York. She holds an MBA from the MIT Sloan School of Management, a Ph.D. in biochemistry from the State University of New York, Stony Brook, and a B.S. in chemistry from Peking University.
